The company’s fourth quarter sales totaled $784 million, compared to nearly $740 million during the same period in 2012. Spine sales dipped from $82 million in 2012 to $67 million in 2013. However, sports, extremities and trauma sales jumped from $98 million to $159 million.
Biomet’s net sales for the year end totaled $3.1 billion, up 7.6 percent from 2012’s $2.8 billion in net sales.
More Articles on Devices:
Wellbe Launches ACL Reconstruction-Specific Patient Guidance System
DJO Global Launches Electric Stimulator to Combat Post-Knee Surgery Muscle Atrophy
11 Spine Devices Receive FDA 510(k) Clearance in June
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
